Maron Eduard, Tõru Innar, Vasar Veiko, Shlik Jakov
Department of Psychiatry, University of Tartu, Raja, Estonia.
J Psychopharmacol. 2004 Jun;18(2):194-9. doi: 10.1177/0269881104042619.
Previous studies suggest a modulatory role of serotonin (5-HT) in experimentally-induced panic attacks. In the current study, we investigated the acute effects of 5-HT precursor l-5-hydroxytryptophan (5-HTP) on the response to panicogenic challenge with cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers. Thirty-two subjects were randomized to receive either 200 mg of 5-HTP or placebo with the CCK-4 challenge following in 90 min in a double-blind, parallel-group design. The results showed a nonsignificant difference between the groups in panic rate (19% after 5-HTP and 44% after placebo, p = 0.13) with a trend for lower intensity of symptoms after 5-HTP (p = 0.08). Further analysis by gender revealed that females in the 5-HTP group had a significantly lower panic rate and intensity of cognitive symptoms whereas, in males, the effect of 5-HTP was limited to lowering the intensity of somatic panic symptoms. Thus, an increased availability of 5-HT may have a gender-dependent protective effect in CCK-4-induced panic.
先前的研究表明血清素(5-羟色胺,5-HT)在实验诱导的惊恐发作中具有调节作用。在本研究中,我们调查了5-HT前体L-5-羟色氨酸(5-HTP)对健康志愿者胆囊收缩素四肽(CCK-4)诱发惊恐反应的急性影响。32名受试者被随机分为两组,分别接受200毫克5-HTP或安慰剂,并在90分钟后接受CCK-4激发试验,采用双盲平行组设计。结果显示,两组的惊恐发作率无显著差异(5-HTP组为19%,安慰剂组为44%,p = 0.13),5-HTP组症状强度有降低趋势(p = 0.08)。按性别进一步分析发现,5-HTP组女性的惊恐发作率和认知症状强度显著较低,而对于男性,5-HTP的作用仅限于降低躯体惊恐症状的强度。因此,5-HT可用性增加可能在CCK-4诱发的惊恐中具有性别依赖性保护作用。